Atrial Fibrillation: News

• EAN 2024 Experts Debate Pros and Cons of Early OAC in Severe Stroke The pros and cons of early vs late initiation of direct OAC after acute ischemic stroke in the setting of AF for secondary prevention, was the topic of a lively debate at the EAN Congress.
  Medscape Medical News, July 05, 2024
• OAC, AF, and Recurrent Stroke Risk: New Data Despite secondary prevention with OAC, the risk for recurrent stroke and mortality is high in patients with AF. However, OAC discontinuation is tied to a doubling of recurrent stroke.
  Medscape Medical News, July 05, 2024
• AHS 2024 New Insight Into CVD, Stroke Risk in Migraine Researchers are delving deeper into the complicated relationships between migraine and cardiovascular and cerebrovascular outcomes.
  Medscape Medical News, June 26, 2024
• ADA 2024 Semaglutide Equally Effective in Women With HFpEF, Obesity Two new analyses of the STEP-HFpEF trials show that semaglutide led to more weight loss in women than in men and that the GLP-1 therapy also improves NYHA class.
  Medscape Medical News, June 24, 2024
• EuroPCR 2024 TAVI Fails Noninferiority to Surgery in Younger Patients In the first-ever randomized controlled trial of younger patients, TAVI did not reach the prespecified noninferiority threshold.
  Medscape Medical News, June 24, 2024
• HRS 2024 Honing Catheter Ablation Techniques for Atrial Fibrillation High-volume centers with more than 100 operators have gathered data on 7000 patients and counting to continually improve outcomes.
  Medscape Medical News, June 24, 2024
• EULAR 2024 Nurse-Led Care for Gout Generates Best Uric Acid Control In patients with gout who have an indication for uric acid lowering, nurse-based management places more patients at target levels and might improve outcomes relative to usual physician-based care.
  Medscape Medical News, June 20, 2024
• ENDO 2024 Debate: Add LT3 If Hypothyroid Symptoms Persist on LT4? At the Endocrine Society's annual meeting, two experts weighed in on the longstanding debate.
  Medscape Medical News, June 18, 2024
• HRS 2024 Anticoagulation Shows No Benefit in Preventing Second Stroke For patients who have had a stroke, anticoagulation with edoxaban didn't reduce the risk for another.
  Medscape Medical News, June 17, 2024
• HRS 2024 Stroke Risk Scale Helps ID Candidates for Anticoagulation The CHA2DS2-VASc stroke risk calculator may clarify which patients with subclinical atrial fibrillation would benefit from anticoagulation.
  Medscape Medical News, June 17, 2024
• HRS 2024 Mediterranean Diet Lowers Tachyarrhythmia in Paroxysmal AF A Mediterranean diet didn't reduce AF recurrence in patients who had undergone ablation, but it did reduce tachyarrhythmia rates in patients with paroxysmal disease.
  Medscape Medical News, June 17, 2024
• SLEEP 2024 Narcolepsy an Independent Cardiovascular Disease Risk Factor Narcolepsy is associated with an increased risk for CVD, independent of common comorbid conditions and medications used to treat the disorder, new research showed.
  Medscape Medical News, June 07, 2024
• Alert FDA Approves Nonstimulant Liquid Onyda XR for ADHD The centrally acting alpha2-adrenergic agonist allows for nighttime dosing and can be used with stimulants, the drug's manufacturer says.
  Medscape Medical News, May 30, 2024
• ESOC 2024 Colchicine a New Tool for Stroke, CVD Event Recurrence? The CONVINCE trial of the anti-inflammatory drug colchicine missed its primary endpoint, but secondary analyses suggested benefit.
  Medscape Medical News, May 29, 2024
• Antiplatelet Therapy and Bleeding After Dental Extraction Conventional methods for managing bleeding after dental extraction may not be sufficient in patients undergoing dual antiplatelet therapy.
  Medscape Medical News, May 28, 2024
• Bleeding Risk Clarified in Stroke Patients Receiving tPA Antiplatelet therapies increased the risk for intracranial hemorrhage in patients with stroke receiving thrombolysis, but the absolute increased risk was small.
  Medscape Medical News, May 23, 2024
• HRS 2024 Athletes With Heart Problems Can Continue to Play An updated consensus statement for managing arrhythmias in athletes focuses on return to play and shared decision-making.
  Medscape Medical News, May 22, 2024
• HFA-ESC 2024 Aficamten Advancing for Cardiomyopathy After SEQUOIA-HCM The investigational oral drug leads to "clinically meaningful" improvements in obstructive hypertrophic cardiomyopathy, a pivotal trial shows.
  Medscape Medical News, May 21, 2024
• Sub-Four-Minute Mile Runners Outlive General Population New evidence about intense running has added to conflicting research about the health effects of extreme exercise.
  Medscape Medical News, May 21, 2024
• ESOC 2024 Mixed Results for Factor Xa Reversal Agent in ICH: ANNEXA-I Full results of the ANNEXA-I trial, showing better control of hematoma expansion but an increase in thrombotic events with andexanet vs usual care, are now published in NEJM.
  Medscape Medical News, May 15, 2024